First Time Loading...

Acutus Medical Inc
NASDAQ:AFIB

Watchlist Manager
Acutus Medical Inc Logo
Acutus Medical Inc
NASDAQ:AFIB
Watchlist
Price: 0.1447 USD -5.3% Market Closed
Updated: May 6, 2024
Section:
 

Wall Street
Price Targets

AFIB Price Targets Summary
Acutus Medical Inc

Wall Street analysts forecast AFIB stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AFIB is 0.5 USD .

AFIB Lowest Forecast
Wall Street Target
Not Available
AFIB Average Forecast
Wall Street Target
0.5 USD
246% Upside
AFIB Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
0.5 USD
246% Upside
Highest
Price Target
Not Available
Acutus Medical Inc Competitors:
Price Targets
SRT
Sartorius AG
59% Upside
NYXH
Nyxoah SA
66% Upside
1733
Apex Biotechnology Corp
123% Upside
301087
Cofoe Medical Technology Co Ltd
30% Upside
SRT
Sartorius AG
59% Upside
NYXH
Nyxoah SA
66% Upside
1733
Apex Biotechnology Corp
123% Upside
301087
Cofoe Medical Technology Co Ltd
30% Upside
DXR
Daxor Corp
142% Upside
NVNO
enVVeno Medical Corp
312% Upside
L
085370
Lutronic Corp
10% Downside
RMD
Resmed Inc
0% Downside

Revenue
Forecast

Revenue Estimate
Acutus Medical Inc

For the last 3 years the compound annual growth rate for Acutus Medical Inc's revenue is 79%. The projected CAGR for the next 3 years is 46%.

79%
Past Growth
46%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Acutus Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
12%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Acutus Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-51%
Average Miss
What are analyst estimates?

See Also

Summary
AFIB intrinsic value, competitors valuation, and company profile.
DCF Valuation
AFIB stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AFIB stock valuation using valuation multiples.
Wall Street Estimates
AFIB price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AFIB stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AFIB's stock price target?
Price Target
0.5 USD

According to Wall Street analysts, the average 1-year price target for AFIB is 0.5 USD .

What is Acutus Medical Inc's Revenue forecast?
Projected CAGR
46%

For the last 3 years the compound annual growth rate for Acutus Medical Inc's revenue is 79%. The projected CAGR for the next 3 years is 46%.

ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.